Home arrow Drug Delivery arrow Companies
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.

Browse

This Category is currently empty.

Latest News

Expert Views: Key decision makers will shape the biosimilars landscape
Read more...
 
Expert Views: Is there an alternative to HRT for menopausal relief?
Read more...
 
Market Research Update W45 2008
Read more...
 

Latest Products


Stakeholder Opinions: Diabetic Renal Disease
Pipeline Insight: Orphan Diseases Myasthenia Gravis

Financial Deals Industry Tracker: Pharma & Healthcare Sep-2008
Sales Force Effectiveness

Forecast Model: Antidyslipidemics
Financial Deals Industry Tracker: Pharma & Healthcare Aug 2008

Stakeholder Insight: Osteoporosis
Pipeline and Commercial Insight: Schizophrenia

Emerging Markets Series: The Pharma Market of South Korea
Merck KGaA: PharmaVitae Profile

Les Laboratoires Servier: PharmaVitae Profile
Solvay S.A.: PharmaVitae Profile

Biogen Idec Inc.: PharmaVitae Profile
Strategic Perspectives: Antidyslipidemics Current market...

M&A trends in Pharma
Commercial Insight: Pain Market Overview

Sepracor Inc.: PharmaVitae Profile
RNA therapy: the next big thing after monoclonal antibodies?

The Top Ten Specialty Pharmaceutical Companies
The Promotional Landscape in US and Europe

Featured Products


Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market
$3 350.00
$2 680.00
You Save: 20.00%

Future Focus: Gastrointestinal Stromal Tumor
$26 250.00
$19 687.50
You Save: 25.00%

Future Focus: Myelodysplastic Syndrome
$26 250.00
$19 687.50
You Save: 25.00%

Cancer Drug Resistance 2008
$2 995.00
$2 396.00
You Save: 20.00%

Search Products

Advanced Search

Product Scroller

Your Cart

Show Cart
Your Cart is currently empty.
Advertisement
 
 
 
© 2008 BioMarket Group